期刊文献+

提倡诊断方法优先 提高直肠癌治疗水平 被引量:5

原文传递
导出
摘要 2009版美国国家癌症综合网络(NCCN)直肠癌临床实践指南(中国版)(下称“中国版指南”)涵括了诊断、多学科评估、辅助及新辅助化放疗、晚期解救及靶向药物治疗等项内容更新。其中在正文首次明确提出“硬性直肠镜”距肛门12cm以内定义为直肠癌的概念应引起重视。去除3cm齿状线,在长度不足10cm的盆腔狭小空间,如何面对追求根治以降低复发及避免手术范围扩大以保全功能和提高生活质量的挑战?进入21世纪,强调治疗前的多学科评估及分期诊断,已成为提高直肠癌规范治疗水平的关键。
作者 刘荫华 徐玲
出处 《中华外科杂志》 CAS CSCD 北大核心 2010年第7期481-483,共3页 Chinese Journal of Surgery
  • 相关文献

参考文献13

  • 1NCCN直肠癌临床实践指南(中国版)专家组.直肠癌临床实践指南(中国版-2009).[2009-12—14].http://www.nccn—asia.org/pdf/2009_Rectal_Cancer_Ch_m.pdf.
  • 2刘荫华.胃肠肿瘤综合诊治的进步与外科医生观念的转变[J].中华胃肠外科杂志,2010,13(1):19-21. 被引量:4
  • 3The NSABP Foundation, Inc. NSABP Clinical Trials Overview. [ 2009-12-18 ]. http ://www. nsabp. pitt. edu/NSABP_Protocols, asp.
  • 4Tjandra JJ, Kilkenny JW, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum,2005,48 : 411-423.
  • 5Karapetis CS, Khambata FS, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med ,2008,359 : 1757-1765.
  • 6Lievre A, Bachet JB, Boige V, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol,2008,26:374-379.
  • 7Van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med ,2009,360 : 1408-1418.
  • 8中国抗癌协会临床肿瘤学协作专业委员会.基因检测大肠癌,靶向治疗个体化.[2009-4-2].http://news.csco.net.cn/class/detail.asp?u=296.
  • 9Zubrod CG, Schneiderman SM, Frei E, et al. Appraisal of methodsfor the study of chemotherapy of cancer in man: Comparativetherapeutic trial of nitrogen mustard and thiophosphamide. J Chronic Dis, 1960,11:7-33.
  • 10Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer, 1981,47:207-214.

二级参考文献8

  • 1World Health Organization.Preventing chronic diseases:a vital investment.2009.http://www.who.int/chp/chronic_disease_report/presentation/en/index.html.
  • 2NCCN胃癌专家组.胃癌临床实践指南(中国版).2009.http://www.nccn-asia.org/pdf/2009_Gastric_Cancer_Ch_m.pdf.
  • 3NCCN结肠癌专家组.结肠癌临床实践指南(中国版).2009.http://www.nccn-asia.org/pdf/2009_Colon_Cancer_Ch_m.pdf.
  • 4NCCN直肠癌专家组.直肠癌临床实践指南(中国版).2009.http://www.nccn-asia.org/pdf/2009_Rectal_Cancer_Ch_m.pdf.
  • 5张俊,陈功.第11届世界胃肠道肿瘤大会会议亮点报道及点评.2009.http://www.24hmb.com/ESM02009/ESMO-Spi/20091029175233.shtml.
  • 6National Surgical Adjuvant Breast and Bowel Project.NSABP CLINICAL TRIALS OVERVIEW.2009.http://www.nsabp.pitt.edu/NSABP_Protocols.asp.
  • 7Eisenhauer EA,Therasse P.New response evaluation criteriain solid tumours:revised RECIST guideline(version 1.1).Eur J Cancer,2009,45(2):228-247.
  • 8Saini A,Norman AR,Cunningham D,et al.Twelve weeks of protracted venous infusion of fluorouracil (5-Fu) and folinic acid as adjuvant treatment in colorectal cancer.Br J Cancer,2003,88(12):1859-1865.

共引文献3

同被引文献31

  • 1叶卫华,赵玉珍.直肠癌腔内多普勒超声与血管病理研究进展[J].中国医学影像学杂志,2005,13(1):46-48. 被引量:4
  • 2Steinert R,Buschmann T,van der Linden M,et al.The role of proteomics in the diagnosis and outcome prediction in colorectal cancer.Technol Cancer Res Treat,2002,1:297-304.
  • 3Zhang ZS,Zhang YL.Progress in research of colorectal cancer in China.Shijie Huaren Xiaohua Zazhi,2001,9:489-494.
  • 4Conway EM,Pollefeyt S,Steiner-Mosonyi M,et al.Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.Gastroenterology,2002,123:619-631.
  • 5Sarela Al,Macadam RC,Farmery SM,et al.Exprssion of the an-ti-apoptosis gene survivin predicts death from recurrent colorectal carcinoma.Cancer Res Clin Oncol,2000,46(5):645-650.
  • 6Rodel F,Hoffmann J,Grabenbauer GG,et al.High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.Strahlenther Onkol,2002,178:426-435.
  • 7Salovaara R,Roth S,Loukola A,et al.Frequent loss of Smad4/ dpc4 protein in colorectal cancers.Gut,2002,51:56-59.
  • 8Nichloas JP,Eric PW,Julie B,et al.Clinical cancer advances 2009:Major research advances in cancer treatment,prevention,and screening-a report from the American Society of Clinical Oncology.J Clin Oncol,2009,27:6052-6069.
  • 9Chun HK,Choi D,Kim MJ. Preoperative staging of rectal cancer:comparison of 3-T high-field MRI and endorectal sonography[J].American Journal of Roentgenology,2006.1557-1562.
  • 10Beynon J,Foy DM,Temple LN. The endosonic appearances of normal colon and rectum[J].Diseases of the Colon & Rectum,1986.810-813.

引证文献5

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部